Cargando…
Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
Annual vaccination is the most effective way to prevent seasonal influenza illness. Instituto Butantan (IB) performed clinical studies with its 2013, 2014 and 2015 seasonal trivalent influenza vaccines (inactivated split-virion). Prospective cohort studies were carried out to describe the safety and...
Autores principales: | Mondini, Gabriella, Braga, Patricia Emilia, Lopes, Marta Heloisa, Sartori, Ana Marli Christovam, Miyaji, Karina Takesaki, Infante, Vanessa, Randi, Bruno Azevedo, Timenetsky, Maria do Carmo Sampaio Tavares, Ferreira, Juliana Caires de Oliveira Achili, Sakita, Neusa Keico, Precioso, Alexander Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069271/ https://www.ncbi.nlm.nih.gov/pubmed/30066805 http://dx.doi.org/10.1590/S1678-9946201860037 |
Ejemplares similares
-
Safety assessment of seasonal trivalent influenza vaccine produced by
Instituto Butantan from 2013 to 2017
por: Gattás, Vera Lúcia, et al.
Publicado: (2018) -
Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies
por: Randi, Bruno Azevedo, et al.
Publicado: (2019) -
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups
por: Vanni, Tazio, et al.
Publicado: (2021) -
Adverse events following yellow fever vaccination in
immunocompromised persons
por: Lara, Amanda Nazareth, et al.
Publicado: (2021) -
Economical Value of Vaccines for the Developing Countries—The Case of Instituto Butantan, a Public Institution in Brazil
por: Ho, Paulo Lee, et al.
Publicado: (2011)